{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:18:26Z","timestamp":1789100306011,"version":"build-2803163510"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"DOI":"10.1007\/s10787-025-01823-w","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T12:03:29Z","timestamp":1750680209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploring potential biomarkers and signaling pathways in neuroinflammation post-traumatic brain injury: insights for synthetic compound-based interventions"],"prefix":"10.1007","author":[{"given":"Mohit","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5703-6117","authenticated-orcid":false,"given":"Akash","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"issue":"2","key":"1823_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5455\/IJMRCR","volume":"2","author":"T Akhigbe","year":"2018","unstructured":"Akhigbe T, Tope AD, Anakwenze A (2018) Role of corticosteroids in the management of acute traumatic brain injury: literature review and critical appraisal of evidence. Int J Med Rev Case Rep 2(2):22. https:\/\/doi.org\/10.5455\/IJMRCR","journal-title":"Int J Med Rev Case Rep"},{"issue":"5","key":"1823_CR2","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.bbadis.2011.10.017","volume":"1822","author":"M Bains","year":"2012","unstructured":"Bains M, Hall ED (2012) Antioxidant therapies in traumatic brain and spinal cord injury. Biochim Biophys Acta 1822(5):675\u2013684. https:\/\/doi.org\/10.1016\/j.bbadis.2011.10.017","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"1823_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1365-2249.2007.03441.x","volume":"149","author":"HE Barksby","year":"2007","unstructured":"Barksby HE, Lea SR, Preshaw PM, Taylor J (2007) The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol 149(2):217\u2013225. https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03441.x","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"1823_CR4","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1097\/00004647-200109000-00009","volume":"21","author":"M Bernardes-Silva","year":"2001","unstructured":"Bernardes-Silva M, Anthony DC, Issekutz AC, Perry VH (2001) Recruitment of neutrophils across the blood\u2013brain barrier: the role of E-and P-selectins. J Cereb Blood Flow Metab 21(9):1115\u20131124. https:\/\/doi.org\/10.1097\/00004647-200109000-00009","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"1823_CR5","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.2174\/1381612826666200113162641","volume":"26","author":"O Binvignat","year":"2020","unstructured":"Binvignat O, Olloquequi J (2020) Excitotoxicity as a target against neurodegenerative processes. Curr Pharm des 26(12):1251\u20131262. https:\/\/doi.org\/10.2174\/1381612826666200113162641","journal-title":"Curr Pharm des"},{"issue":"12","key":"1823_CR6","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1113\/EP085135","volume":"100","author":"D Brough","year":"2015","unstructured":"Brough D, Rothwell NJ, Allan SM (2015) Interleukin-1 as a pharmacological target in acute brain injury. Exp Physiol 100(12):1488\u20131494. https:\/\/doi.org\/10.1113\/EP085135","journal-title":"Exp Physiol"},{"issue":"2","key":"1823_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.mcna.2019.11.001","volume":"104","author":"A Capizzi","year":"2020","unstructured":"Capizzi A, Woo J, Verduzco-Gutierrez M (2020) Traumatic brain injury: an overview of epidemiology, pathophysiology, and medical management. Med Clin 104(2):213\u2013238. https:\/\/doi.org\/10.1016\/j.mcna.2019.11.001","journal-title":"Med Clin"},{"issue":"9","key":"1823_CR8","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.3390\/ijms21093344","volume":"21","author":"A Cash","year":"2020","unstructured":"Cash A, Theus MH (2020) Mechanisms of blood-brain barrier dysfunction in traumatic brain injury. Int J Mol Sci 21(9):3344. https:\/\/doi.org\/10.3390\/ijms21093344","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1823_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.535","volume":"7","author":"MS Castelli","year":"2019","unstructured":"Castelli MS, McGonigle P, Hornby PJ (2019) The pharmacology and therapeutic applications of monoclonal antibodies. Pharmacol Res Perspect 7(6):e00535. https:\/\/doi.org\/10.1002\/prp2.535","journal-title":"Pharmacol Res Perspect"},{"key":"1823_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O (2017) Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol 35:441\u2013468. https:\/\/doi.org\/10.1146\/annurev-immunol-051116-052358","journal-title":"Annu Rev Immunol"},{"issue":"15","key":"1823_CR11","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.3390\/nu16152430","volume":"16","author":"F Conti","year":"2024","unstructured":"Conti F, McCue JJ, DiTuro P, Galpin AJ, Wood TR (2024) Mitigating traumatic brain injury: a narrative review of supplementation and dietary protocols. Nutrients 16(15):2430. https:\/\/doi.org\/10.3390\/nu16152430","journal-title":"Nutrients"},{"issue":"3","key":"1823_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/jamaneurol.2014.3558","volume":"72","author":"KN Corps","year":"2015","unstructured":"Corps KN, Roth TL, McGavern DB (2015) Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol 72(3):355\u2013362. https:\/\/doi.org\/10.1001\/jamaneurol.2014.3558","journal-title":"JAMA Neurol"},{"issue":"1","key":"1823_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","volume":"335","author":"AE Coutinho","year":"2011","unstructured":"Coutinho AE, Chapman KE (2011) The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol 335(1):2\u201313. https:\/\/doi.org\/10.1016\/j.mce.2010.04.005","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"1823_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024648","volume":"6","author":"PK Dash","year":"2011","unstructured":"Dash PK, Johnson D, Clark J, Orsi SA, Zhang M, Zhao J, Grill RJ, Moore AN, Pati S (2011) Involvement of the glycogen synthase kinase-3 signaling pathway in TBI pathology and neurocognitive outcome. PLoS ONE 6(9):e24648. https:\/\/doi.org\/10.1371\/journal.pone.0024648","journal-title":"PLoS ONE"},{"issue":"2","key":"1823_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.gendis.2019.05.002","volume":"7","author":"Y Deng","year":"2020","unstructured":"Deng Y, Jiang X, Deng X, Chen H, Xu J, Zhang Z, Liu G, Yong Z, Yuan C, Sun X, Wang C (2020) Pioglitazone ameliorates neuronal damage after traumatic brain injury via the PPAR\u03b3\/NF-\u03baB\/IL-6 signaling pathway. Genes Dis 7(2):253\u2013265. https:\/\/doi.org\/10.1016\/j.gendis.2019.05.002","journal-title":"Genes Dis"},{"issue":"2","key":"1823_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1089\/neu.2013.3019","volume":"31","author":"R Diaz-Arrastia","year":"2014","unstructured":"Diaz-Arrastia R, Kochanek PM, Bergold P, Kenney K, Marx CE, Grimes CJ, Loh LY, Adam LG, Oskvig D, Curley KC, Salzer CW (2014) Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup. J Neurotrauma 31(2):135\u2013158. https:\/\/doi.org\/10.1089\/neu.2013.3019","journal-title":"J Neurotrauma"},{"key":"1823_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.brainres.2015.12.034","volume":"1640","author":"WD Dietrich","year":"2016","unstructured":"Dietrich WD, Bramlett HM (2016) Therapeutic hypothermia and targeted temperature management in traumatic brain injury: clinical challenges for successful translation. Brain Res 1640:94\u2013103. https:\/\/doi.org\/10.1016\/j.brainres.2015.12.034","journal-title":"Brain Res"},{"issue":"1","key":"1823_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","volume":"27","author":"CA Dinarello","year":"2009","unstructured":"Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27(1):519\u2013550. https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132612","journal-title":"Annu Rev Immunol"},{"key":"1823_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc1252","volume":"4","author":"G Dranoff","year":"2004","unstructured":"Dranoff G (2004) Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4:11\u201322. https:\/\/doi.org\/10.1038\/nrc1252","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1823_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.expneurol.2005.12.002","volume":"198","author":"CI Dubreuil","year":"2006","unstructured":"Dubreuil CI, Marklund N, Deschamps K, McIntosh TK, McKerracher L (2006) Activation of Rho after traumatic brain injury and seizure in rats. Exp Neurol 198(2):361\u2013369. https:\/\/doi.org\/10.1016\/j.expneurol.2005.12.002","journal-title":"Exp Neurol"},{"issue":"4","key":"1823_CR21","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1592\/phco.26.4.515","volume":"26","author":"HF Elewa","year":"2006","unstructured":"Elewa HF, Hilali H, Hess DC, Machado LS, Fagan SC (2006) Minocycline for short-term neuroprotection. Pharmacotherapy 26(4):515\u2013521. https:\/\/doi.org\/10.1592\/phco.26.4.515","journal-title":"Pharmacotherapy"},{"issue":"2","key":"1823_CR22","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/TA.0000000000003000","volume":"90","author":"M ElSaadani","year":"2021","unstructured":"ElSaadani M, Ahmed SM, Jacovides C, Lopez A, Johnson VE, Kaplan LJ, Schwab CW, Smith DH, Pascual JL (2021) Antithrombin III ameliorates post\u2013traumatic brain injury cerebral leukocyte mobilization enhancing recovery of blood brain barrier integrity. J Trauma Acute Care Surg 90(2):274\u2013280. https:\/\/doi.org\/10.1097\/TA.0000000000003000","journal-title":"J Trauma Acute Care Surg"},{"issue":"9","key":"1823_CR23","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.7150\/ijbs.4679","volume":"8","author":"M Erta","year":"2012","unstructured":"Erta M, Quintana A, Hidalgo J (2012) Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 8(9):1254. https:\/\/doi.org\/10.7150\/ijbs.4679","journal-title":"Int J Biol Sci"},{"issue":"127","key":"1823_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-444-52892-6.00001-5","volume":"1","author":"M Faul","year":"2015","unstructured":"Faul M, Coronado V (2015) Epidemiology of traumatic brain injury. Handb Clin Neurol 1(127):3\u201313. https:\/\/doi.org\/10.1016\/B978-0-444-52892-6.00001-5","journal-title":"Handb Clin Neurol"},{"issue":"9","key":"1823_CR25","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3390\/biom12091299","volume":"12","author":"TA Fedotcheva","year":"2022","unstructured":"Fedotcheva TA, Fedotcheva NI, Shimanovsky NL (2022) Progesterone as an anti-inflammatory drug and immunomodulator: new aspects in hormonal regulation of the inflammation. Biomolecules 12(9):1299. https:\/\/doi.org\/10.3390\/biom12091299","journal-title":"Biomolecules"},{"issue":"2","key":"1823_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5114\/fn.2022.118184","volume":"60","author":"Y Feng","year":"2022","unstructured":"Feng Y, Ju Y, Yan Z, Ji M, Li J, Wu Q, Yang M, Sun G (2022) Resveratrol attenuates autophagy and inflammation after traumatic brain injury by activation of PI3K\/Akt\/mTOR pathway in rats. Folia Neuropathol 60(2):153\u2013164. https:\/\/doi.org\/10.5114\/fn.2022.118184","journal-title":"Folia Neuropathol"},{"issue":"21","key":"1823_CR27","doi-asserted-by":"publisher","first-page":"13000","DOI":"10.3390\/ijms232113000","volume":"23","author":"A Fesharaki-Zadeh","year":"2022","unstructured":"Fesharaki-Zadeh A (2022) Oxidative stress in traumatic brain injury. Int J Mol Sci 23(21):13000. https:\/\/doi.org\/10.3390\/ijms232113000","journal-title":"Int J Mol Sci"},{"key":"1823_CR28","doi-asserted-by":"publisher","first-page":"1371213","DOI":"10.3389\/fncel.2024.1371213","volume":"18","author":"A Fesharaki-Zadeh","year":"2024","unstructured":"Fesharaki-Zadeh A, Datta D (2024) An overview of preclinical models of traumatic brain injury (TBI): relevance to pathophysiological mechanisms. Front Cell Neurosci 18:1371213. https:\/\/doi.org\/10.3389\/fncel.2024.1371213","journal-title":"Front Cell Neurosci"},{"key":"1823_CR29","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fneur.2017.00244","volume":"8","author":"JM Garcia","year":"2017","unstructured":"Garcia JM, Stillings SA, Leclerc JL, Phillips H, Edwards NJ, Robicsek SA, Hoh BL, Blackburn S, Dor\u00e9 S (2017) Role of interleukin-10 in acute brain injuries. Front Neurol 8:244. https:\/\/doi.org\/10.3389\/fneur.2017.00244","journal-title":"Front Neurol"},{"issue":"9233","key":"1823_CR30","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S0140-6736(00)02689-1","volume":"356","author":"J Ghajar","year":"2000","unstructured":"Ghajar J (2000) Traumatic brain injury. The Lancet 356(9233):923\u2013929. https:\/\/doi.org\/10.1016\/S0140-6736(00)02689-1","journal-title":"The Lancet"},{"key":"1823_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.635483","volume":"15","author":"MK Ghiam","year":"2021","unstructured":"Ghiam MK, Patel SD, Hoffer A, Selman WR, Hoffer BJ, Hoffer ME (2021) Drug repurposing in the treatment of traumatic brain injury. Front Neurosci 15:635483. https:\/\/doi.org\/10.3389\/fnins.2021.635483","journal-title":"Front Neurosci"},{"issue":"20","key":"1823_CR32","doi-asserted-by":"publisher","first-page":"7080","DOI":"10.3390\/molecules27207080","volume":"27","author":"Y Guo","year":"2022","unstructured":"Guo Y, Dai W, Zheng Y, Qiao W, Chen W, Peng L, Zhou H, Zhao T, Liu H, Zheng F, Sun P (2022) Mechanism and regulation of microglia polarization in intracerebral hemorrhage. Molecules 27(20):7080. https:\/\/doi.org\/10.3390\/molecules27207080","journal-title":"Molecules"},{"issue":"23","key":"1823_CR33","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1089\/neu.2021.0062","volume":"38","author":"J Haarbauer-Krupa","year":"2021","unstructured":"Haarbauer-Krupa J, Pugh MJ, Prager EM, Harmon N, Wolfe J, Yaffe K (2021) Epidemiology of chronic effects of traumatic brain injury. J Neurotrauma 38(23):3235\u20133247. https:\/\/doi.org\/10.1089\/neu.2021.0062","journal-title":"J Neurotrauma"},{"issue":"1\u20132","key":"1823_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.brainres.2004.12.051","volume":"1037","author":"T Hayashi","year":"2005","unstructured":"Hayashi T, Hamakawa K, Nagotani S et al (2005) HMG CoA reductase inhibitors reduce ischemic brain injury of Wistar rats through decreasing oxidative stress on neurons. Brain Res 1037(1\u20132):52\u201358. https:\/\/doi.org\/10.1016\/j.brainres.2004.12.051","journal-title":"Brain Res"},{"issue":"5","key":"1823_CR35","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.3390\/jcm12051793","volume":"12","author":"A Herrero Babiloni","year":"2023","unstructured":"Herrero Babiloni A, Baril AA, Charlebois-Plante C, Jodoin M, Sanchez E, De Baets L, Arbour C, Lavigne GJ, Gosselin N, De Beaumont L (2023) The putative role of neuroinflammation in the interaction between traumatic brain injuries, sleep, pain and other neuropsychiatric outcomes: a state-of-the-art review. J Clin Med 12(5):1793. https:\/\/doi.org\/10.3390\/jcm12051793","journal-title":"J Clin Med"},{"issue":"1","key":"1823_CR36","doi-asserted-by":"publisher","first-page":"4921562","DOI":"10.1155\/2020\/4921562","volume":"2020","author":"L Huang","year":"2020","unstructured":"Huang L, Tang H, Sherchan P, Lenahan C, Boling W, Tang J, Zhang JH (2020) The Activation of Phosphatidylserine\/CD36\/TGF-\u03b21 Pathway prior to Surgical Brain Injury Attenuates Neuroinflammation in Rats. Oxid Med Cell Longev 2020(1):4921562. https:\/\/doi.org\/10.1155\/2020\/4921562","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"1823_CR37","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.3390\/biomedicines11082129","volume":"11","author":"G Inoue","year":"2023","unstructured":"Inoue G, Ohtaki Y, Satoh K, Odanaka Y, Katoh A, Suzuki K, Tomita Y, Eiraku M, Kikuchi K, Harano K, Yagi M (2023) Sedation therapy in intensive care units: harnessing the power of antioxidants to combat oxidative stress. Biomedicines 11(8):2129. https:\/\/doi.org\/10.3390\/biomedicines11082129","journal-title":"Biomedicines"},{"issue":"19","key":"1823_CR38","doi-asserted-by":"publisher","first-page":"11193","DOI":"10.3390\/ijms231911193","volume":"23","author":"A Jacquens","year":"2022","unstructured":"Jacquens A, Needham EJ, Zanier ER, Degos V, Gressens P, Menon D (2022) Neuro-inflammation modulation and post-traumatic brain injury lesions: from bench to bed-side. Int J Mol Sci 23(19):11193. https:\/\/doi.org\/10.3390\/ijms231911193","journal-title":"Int J Mol Sci"},{"key":"1823_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2022.08.014","volume":"254","author":"NH Johnson","year":"2023","unstructured":"Johnson NH, de Rivero Vaccari JP, Bramlett HM, Keane RW, Dietrich WD (2023) Inflammasome activation in traumatic brain injury and Alzheimer\u2019s disease. Transl Res 254:1\u20132. https:\/\/doi.org\/10.1016\/j.trsl.2022.08.014","journal-title":"Transl Res"},{"issue":"3","key":"1823_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1503\/jpn.120065","volume":"37","author":"R Joober","year":"2012","unstructured":"Joober R, Schmitz N, Annable L, Boksa P (2012) Publication bias: what are the challenges and can they be overcome? J Psychiatry Neurosci 37(3):149\u2013152. https:\/\/doi.org\/10.1503\/jpn.120065","journal-title":"J Psychiatry Neurosci"},{"issue":"9","key":"1823_CR41","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.3390\/biom11091361","volume":"11","author":"AM Jurga","year":"2021","unstructured":"Jurga AM, Paleczna M, Kadluczka J, Kuter KZ (2021) Beyond the GFAP-astrocyte protein markers in the brain. Biomolecules 11(9):1361. https:\/\/doi.org\/10.3390\/biom11091361","journal-title":"Biomolecules"},{"issue":"4","key":"1823_CR42","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s10787-022-01017-8","volume":"30","author":"S Kalra","year":"2022","unstructured":"Kalra S, Malik R, Singh G, Bhatia S, Al-Harrasi A, Mohan S, Albratty M, Albarrati A, Tambuwala MM (2022) Pathogenesis and management of traumatic brain injury (TBI): role of neuroinflammation and anti-inflammatory drugs. Inflammopharmacology 30(4):1153\u20131166. https:\/\/doi.org\/10.1007\/s10787-022-01017-8","journal-title":"Inflammopharmacology"},{"key":"1823_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107778","volume":"96","author":"F Kanso","year":"2021","unstructured":"Kanso F, Khalil A, Noureddine H, El-Makhour Y (2021) Therapeutic perspective of thiosemicarbazones derivatives in inflammatory pathologies: a summary of in vitro\/in vivo studies. Int Immunopharmacol 96:107778. https:\/\/doi.org\/10.1016\/j.intimp.2021.107778","journal-title":"Int Immunopharmacol"},{"issue":"22","key":"1823_CR44","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.3390\/healthcare12222266","volume":"12","author":"MA Karaboue","year":"2024","unstructured":"Karaboue MA, Ministeri F, Sessa F, Nannola C, Chisari MG, Cocimano G, Di Mauro L, Salerno M, Esposito M (2024) Traumatic brain injury as a public health issue: epidemiology, prognostic factors and useful data from forensic practice. InHealthcare 12(22):2266. https:\/\/doi.org\/10.3390\/healthcare12222266","journal-title":"InHealthcare"},{"key":"1823_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neuroscience.2022.03.016","volume":"491","author":"H Khan","year":"2022","unstructured":"Khan H, Grewal AK, Singh TG (2022) Pharmacological postconditioning by protocatechuic acid attenuates brain injury in ischemia\u2013reperfusion (I\/R) mice model: implications of nuclear factor erythroid-2-related factor pathway. Neuroscience 491:23\u201331. https:\/\/doi.org\/10.1016\/j.neuroscience.2022.03.016","journal-title":"Neuroscience"},{"issue":"1","key":"1823_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s13311-010-0003-3","volume":"8","author":"JJ Kim","year":"2011","unstructured":"Kim JJ, Gean AD (2011) Imaging for the diagnosis and management of traumatic brain injury. Neurotherapeutics 8(1):39\u201353. https:\/\/doi.org\/10.1007\/s13311-010-0003-3","journal-title":"Neurotherapeutics"},{"key":"1823_CR47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbi.2016.12.005","volume":"61","author":"M Lagraoui","year":"2017","unstructured":"Lagraoui M, Sukumar G, Latoche JR, Maynard SK, Dalgard CL, Schaefer BC (2017) Salsalate treatment following traumatic brain injury reduces inflammation and promotes a neuroprotective and neurogenic transcriptional response with concomitant functional recovery. Brain Behav Immun 61:96\u2013109. https:\/\/doi.org\/10.1016\/j.bbi.2016.12.005","journal-title":"Brain Behav Immun"},{"issue":"6","key":"1823_CR48","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1021\/cn500040g","volume":"5","author":"PR Leeds","year":"2014","unstructured":"Leeds PR, Yu F, Wang Z, Chiu CT, Zhang Y, Leng Y, Linares GR, Chuang DM (2014) A new avenue for lithium: intervention in traumatic brain injury. ACS Chem Neurosci 5(6):422\u2013433. https:\/\/doi.org\/10.1021\/cn500040g","journal-title":"ACS Chem Neurosci"},{"key":"1823_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-3-15","volume":"3","author":"HW Lin","year":"2006","unstructured":"Lin HW, Basu A, Druckman C, Cicchese M, Krady JK, Levison SW (2006) Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury. J Neuroinflammation 3:1\u20131. https:\/\/doi.org\/10.1186\/1742-2094-3-15","journal-title":"J Neuroinflammation"},{"issue":"5","key":"1823_CR50","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S1474-4422(10)70065-X","volume":"9","author":"HF Lingsma","year":"2010","unstructured":"Lingsma HF, Roozenbeek B, Steyerberg EW, Murray GD, Maas AI (2010) Early prognosis in traumatic brain injury: from prophecies to predictions. Lancet Neurol 9(5):543\u2013554. https:\/\/doi.org\/10.1016\/S1474-4422(10)70065-X","journal-title":"Lancet Neurol"},{"key":"1823_CR51","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11302-017-9579-y","volume":"13","author":"X Liu","year":"2017","unstructured":"Liu X, Zhao Z, Ji R, Zhu J, Sui QQ, Knight GE, Burnstock G, He C, Yuan H, Xiang Z (2017) Inhibition of P2X7 receptors improves outcomes after traumatic brain injury in rats. Purinergic Signal 13:529\u2013544. https:\/\/doi.org\/10.1007\/s11302-017-9579-y","journal-title":"Purinergic Signal"},{"issue":"6","key":"1823_CR52","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1080\/15384101.2024.2355008","volume":"23","author":"X Liu","year":"2024","unstructured":"Liu X, Gu J, Wang C, Peng M, Zhou J, Fei X, Zhong Z, Li B (2024) Ginsenoside Rg3 attenuates neuroinflammation and hippocampal neuronal damage after traumatic brain injury in mice by inactivating the NF-kB pathway via SIRT1 activation. Cell Cycle 23(6):662\u2013681. https:\/\/doi.org\/10.1080\/15384101.2024.2355008","journal-title":"Cell Cycle"},{"key":"1823_CR53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuint.2015.08.009","volume":"89","author":"MS Lopez","year":"2015","unstructured":"Lopez MS, Dempsey RJ, Vemuganti R (2015) Resveratrol neuroprotection in stroke and traumatic CNS injury. Neurochem Int 89:75\u201382. https:\/\/doi.org\/10.1016\/j.neuint.2015.08.009","journal-title":"Neurochem Int"},{"issue":"1","key":"1823_CR54","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.neulet.2005.05.057","volume":"386","author":"KT Lu","year":"2005","unstructured":"Lu KT, Wang YW, Wo YY, Yang YL (2005) Extracellular signal-regulated kinase-mediated IL-1-induced cortical neuron damage during traumatic brain injury. Neurosci Lett 386(1):40\u201345. https:\/\/doi.org\/10.1016\/j.neulet.2005.05.057","journal-title":"Neurosci Lett"},{"issue":"6","key":"1823_CR55","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3390\/jcm12062179","volume":"12","author":"DG Lynch","year":"2023","unstructured":"Lynch DG, Narayan RK, Li C (2023) Multi-mechanistic approaches to the treatment of traumatic brain injury: a review. J Clin Med 12(6):2179. https:\/\/doi.org\/10.3390\/jcm12062179","journal-title":"J Clin Med"},{"key":"1823_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008409.pub4","author":"J Ma","year":"2016","unstructured":"Ma J, Huang S, Qin S, You C, Zeng Y (2016) Progesterone for acute traumatic brain injury. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD008409.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1823_CR57","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S1474-4422(05)70253-2","volume":"5","author":"AI Maas","year":"2006","unstructured":"Maas AI, Murray G, Henney H, Kassem N, Legrand V, Mangelus M, Muizelaar JP, Stocchetti N, Knoller N (2006) Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurol 5(1):38\u201345. https:\/\/doi.org\/10.1016\/S1474-4422(05)70253-2","journal-title":"Lancet Neurol"},{"issue":"12","key":"1823_CR58","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S1474-4422(17)30371-X","volume":"16","author":"AI Maas","year":"2017","unstructured":"Maas AI, Menon DK, Adelson PD, Andelic N, Bell MJ, Belli A, Bragge P, Brazinova A, B\u00fcki A, Chesnut RM, Citerio G (2017) Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. Lancet Neurol 16(12):987\u20131048. https:\/\/doi.org\/10.1016\/S1474-4422(17)30371-X","journal-title":"Lancet Neurol"},{"issue":"13","key":"1823_CR59","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.2174\/138161206776843340","volume":"12","author":"N Marklund","year":"2006","unstructured":"Marklund N, Bakshi A, Castelbuono DJ, Conte V, McIntosh TK (2006) Evaluation of pharmacological treatment strategies in traumatic brain injury. Curr Pharm des 12(13):1645\u20131680. https:\/\/doi.org\/10.2174\/138161206776843340","journal-title":"Curr Pharm des"},{"key":"1823_CR60","doi-asserted-by":"publisher","DOI":"10.3171\/2021.3.JNS204163","author":"I Masse","year":"2021","unstructured":"Masse I, Moquin L, Bouchard C et al (2021) Efficacy of prophylactic versus therapeutic administration of the NMDA receptor antagonist MK-801 on the acute neurochemical response to a concussion in a rat model combining force and rotation. J Neurosurg. https:\/\/doi.org\/10.3171\/2021.3.JNS204163","journal-title":"J Neurosurg"},{"key":"1823_CR61","volume-title":"Traumatic brain injury: a roadmap for accelerating progress","author":"C Matney","year":"2022","unstructured":"Matney C, Bowman K, Berwick D (2022) National Academies of Sciences, Engineering, and Medicine. Rehabilitation and long-term care needs after traumatic brain injury. Traumatic brain injury: a roadmap for accelerating progress. National Academies Press"},{"issue":"3","key":"1823_CR62","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1172\/JCI11916","volume":"107","author":"MP Mattson","year":"2001","unstructured":"Mattson MP, Camandola S (2001) NF-\u03baB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 107(3):247\u2013254. https:\/\/doi.org\/10.1172\/JCI11916","journal-title":"J Clin Invest"},{"issue":"10","key":"1823_CR63","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.3390\/cancers12102751","volume":"12","author":"C Megino-Luque","year":"2020","unstructured":"Megino-Luque C, Moiola CP, Molins-Escuder C, L\u00f3pez-Gil C, Gil-Moreno A, Matias-Guiu X, Colas E, Eritja N (2020) Small-molecule inhibitors (SMIs) as an effective therapeutic strategy for endometrial cancer. Cancers (Basel) 12(10):2751. https:\/\/doi.org\/10.3390\/cancers12102751","journal-title":"Cancers (Basel)"},{"issue":"12","key":"1823_CR64","doi-asserted-by":"publisher","first-page":"6418","DOI":"10.3390\/ijms22126418","volume":"22","author":"S Michinaga","year":"2021","unstructured":"Michinaga S, Koyama Y (2021) Pathophysiological responses and roles of astrocytes in traumatic brain injury. Int J Mol Sci 22(12):6418. https:\/\/doi.org\/10.3390\/ijms22126418","journal-title":"Int J Mol Sci"},{"key":"1823_CR65","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.thromres.2020.08.002","volume":"193","author":"MC Morris","year":"2020","unstructured":"Morris MC, John D, Singer KE et al (2020) Post-TBI splenectomy may exacerbate coagulopathy and platelet activation in a murine model. Thromb Res 193:211\u2013217. https:\/\/doi.org\/10.1016\/j.thromres.2020.08.002","journal-title":"Thromb Res"},{"key":"1823_CR66","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fncel.2015.00018","volume":"9","author":"KN Murray","year":"2015","unstructured":"Murray KN, Parry-Jones AR, Allan SM (2015) Interleukin-1 and acute brain injury. Front Cell Neurosci 9:18. https:\/\/doi.org\/10.3389\/fncel.2015.00018","journal-title":"Front Cell Neurosci"},{"key":"1823_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.742065","volume":"15","author":"L Muzio","year":"2021","unstructured":"Muzio L, Viotti A, Martino G (2021) Microglia in neuroinflammation and neurodegeneration: from understanding to therapy. Front Neurosci 15:742065. https:\/\/doi.org\/10.3389\/fnins.2021.742065","journal-title":"Front Neurosci"},{"issue":"1","key":"1823_CR68","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2990.2010.01138.x","volume":"37","author":"S Nag","year":"2011","unstructured":"Nag S, Kapadia A, Stewart DJ (2011) Molecular pathogenesis of blood\u2013brain barrier breakdown in acute brain injury. Neuropathol Appl Neurobiol 37(1):3\u201323. https:\/\/doi.org\/10.1111\/j.1365-2990.2010.01138.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1823_CR69","unstructured":"Nicolaides NC, Chrousos G, Kino T (2020) Glucocorticoid receptor. Endotext [Internet]."},{"issue":"7","key":"1823_CR70","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1097\/00003246-199707000-00010","volume":"25","author":"SM Opal","year":"1997","unstructured":"Opal SM, Fisher CJ Jr, Dhainaut JF et al (1997) Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med 25(7):1115\u20131124. https:\/\/doi.org\/10.1097\/00003246-199707000-00010","journal-title":"Crit Care Med"},{"issue":"3","key":"1823_CR71","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/00004647-200203000-00010","volume":"22","author":"N Otani","year":"2002","unstructured":"Otani N, Nawashiro H, Fukui S, Nomura N, Yano A, Miyazawa T, Shima K (2002) Differential activation of mitogen-activated protein kinase pathways after traumatic brain injury in the rat hippocampus. J Cereb Blood Flow Metab 22(3):327\u2013334. https:\/\/doi.org\/10.1097\/00004647-200203000-00010","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"1823_CR72","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/pr.58.3.2","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher P, B\u00e1tkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58(3):389\u2013462. https:\/\/doi.org\/10.1124\/pr.58.3.2","journal-title":"Pharmacol Rev"},{"issue":"1","key":"1823_CR73","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cyto.2015.06.017","volume":"76","author":"J Palomo","year":"2015","unstructured":"Palomo J, Dietrich D, Martin P, Palmer G, Gabay C (2015) The interleukin (IL)-1 cytokine family\u2013Balance between agonists and antagonists in inflammatory diseases. Cytokine 76(1):25\u201337. https:\/\/doi.org\/10.1016\/j.cyto.2015.06.017","journal-title":"Cytokine"},{"key":"1823_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113518","volume":"335","author":"S Paul","year":"2021","unstructured":"Paul S, Candelario-Jalil E (2021) Emerging neuroprotective strategies for the treatment of ischemic stroke: an overview of clinical and preclinical studies. Exp Neurol 335:113518. https:\/\/doi.org\/10.1016\/j.expneurol.2020.113518","journal-title":"Exp Neurol"},{"issue":"1","key":"1823_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-191150","volume":"74","author":"TT Postolache","year":"2020","unstructured":"Postolache TT, Wadhawan A, Can A et al (2020a) Inflammation in traumatic brain injury. J Alzheimers Dis 74(1):1\u201328. https:\/\/doi.org\/10.3233\/JAD-191150","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1823_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-191150","volume":"74","author":"TT Postolache","year":"2020","unstructured":"Postolache TT, Wadhawan A, Can A, Lowry CA, Woodbury M, Makkar H, Hoisington AJ, Scott AJ, Potocki E, Benros ME, Stiller JW (2020b) Inflammation in traumatic brain injury. J Alzheimers Dis 74(1):1\u201328. https:\/\/doi.org\/10.3233\/JAD-191150","journal-title":"J Alzheimers Dis"},{"key":"1823_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108902","volume":"108","author":"NK Prabhakar","year":"2022","unstructured":"Prabhakar NK, Khan H, Grewal AK, Singh TG (2022) Intervention of neuroinflammation in the traumatic brain injury trajectory: in vivo and clinical approaches. Int Immunopharmacol 108:108902. https:\/\/doi.org\/10.1016\/j.intimp.2022.108902","journal-title":"Int Immunopharmacol"},{"issue":"271","key":"1823_CR78","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.expneurol.2015.07.001","volume":"1","author":"DJ Raible","year":"2015","unstructured":"Raible DJ, Frey LC, Del Angel YC, Carlsen J, Hund D, Russek SJ, Smith B, Brooks-Kayal AR (2015) JAK\/STAT pathway regulation of GABAA receptor expression after differing severities of experimental TBI. Exp Neurol 1(271):445\u2013456. https:\/\/doi.org\/10.1016\/j.expneurol.2015.07.001","journal-title":"Exp Neurol"},{"issue":"7","key":"1823_CR79","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.21873\/anticanres.15110","volume":"41","author":"KS Rallis","year":"2021","unstructured":"Rallis KS, Corrigan AE, Dadah H et al (2021) Cytokine-based cancer immunotherapy: challenges and opportunities for IL-10. Anticancer Res 41(7):3247\u20133252. https:\/\/doi.org\/10.21873\/anticanres.15110","journal-title":"Anticancer Res"},{"issue":"1562","key":"1823_CR80","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1098\/rstb.2010.0230","volume":"366","author":"JE Risdall","year":"2011","unstructured":"Risdall JE, Menon DK (2011) Traumatic brain injury. Philos Trans R Soc B Biol Sci 366(1562):241\u2013250. https:\/\/doi.org\/10.1098\/rstb.2010.0230","journal-title":"Philos Trans R Soc B Biol Sci"},{"issue":"1","key":"1823_CR81","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1001\/jama.2014.6490","volume":"312","author":"CS Robertson","year":"2014","unstructured":"Robertson CS, Hannay HJ, Yamal JM, Gopinath S, Goodman JC, Tilley BC, Baldwin A, Lara LR, Saucedo-Crespo H, Ahmed O, Sadasivan S (2014) Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. JAMA 312(1):36\u201347. https:\/\/doi.org\/10.1001\/jama.2014.6490","journal-title":"JAMA"},{"issue":"5","key":"1823_CR82","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1212\/CON.0000000000001036","volume":"27","author":"CP Robinson","year":"2021","unstructured":"Robinson CP (2021) Moderate and severe traumatic brain injury. Continuum (Minneap Minn) 27(5):1278\u20131300. https:\/\/doi.org\/10.1212\/CON.0000000000001036","journal-title":"Continuum (Minneap Minn)"},{"issue":"3","key":"1823_CR83","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0889-1591(02)00098-3","volume":"17","author":"N Rothwell","year":"2003","unstructured":"Rothwell N (2003) Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential. Brain Behav Immun 17(3):152\u2013157. https:\/\/doi.org\/10.1016\/S0889-1591(02)00098-3","journal-title":"Brain Behav Immun"},{"issue":"6301","key":"1823_CR84","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1126\/science.aaf6260","volume":"353","author":"MV Russo","year":"2016","unstructured":"Russo MV, McGavern DB (2016) Inflammatory neuroprotection following traumatic brain injury. Science 353(6301):783\u2013785. https:\/\/doi.org\/10.1126\/science.aaf6260","journal-title":"Science"},{"key":"1823_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134347","volume":"710","author":"DK Sahel","year":"2019","unstructured":"Sahel DK, Kaira M, Raj K, Sharma S, Singh S (2019) Mitochondrial dysfunctioning and neuroinflammation: recent highlights on the possible mechanisms involved in traumatic brain Injury. Neurosci Lett 710:134347. https:\/\/doi.org\/10.1016\/j.neulet.2019.134347","journal-title":"Neurosci Lett"},{"key":"1823_CR86","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00068-004-1394-9","volume":"30","author":"OI Schmidt","year":"2004","unstructured":"Schmidt OI, Infanger M, Heyde CE, Ertel W, Stahel PF (2004) The role of neuroinflammation in traumatic brain injury. Eur J Trauma 30:135\u2013149. https:\/\/doi.org\/10.1007\/s00068-004-1394-9","journal-title":"Eur J Trauma"},{"issue":"2","key":"1823_CR87","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.brainresrev.2004.12.028","volume":"48","author":"OI Schmidt","year":"2005","unstructured":"Schmidt OI, Heyde CE, Ertel W, Stahel PF (2005) Closed head injury\u2014an inflammatory disease? Brain Res Rev 48(2):388\u2013399. https:\/\/doi.org\/10.1016\/j.brainresrev.2004.12.028","journal-title":"Brain Res Rev"},{"key":"1823_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.825086","volume":"14","author":"F Shao","year":"2022","unstructured":"Shao F, Wang X, Wu H, Wu Q, Zhang J (2022) Microglia and neuroinflammation: crucial pathological mechanisms in traumatic brain injury-induced neurodegeneration. Front Aging Neurosci 14:825086. https:\/\/doi.org\/10.3389\/fnagi.2022.825086","journal-title":"Front Aging Neurosci"},{"key":"1823_CR89","doi-asserted-by":"publisher","first-page":"01021","DOI":"10.3389\/fphar.2020.01021","volume":"11","author":"J Sharifi-Rad","year":"2020","unstructured":"Sharifi-Rad J, Rayess YE, Rizk AA, Sadaka C, Zgheib R, Zam W, Sestito S, Rapposelli S, Neffe-Skoci\u0144ska K, Zieli\u0144ska D, Salehi B, Setzer WN, Dosoky NS, Taheri Y, El Beyrouthy M, Martorell M, Ostrander EA, Suleria HAR, Cho WC, Maroyi A, Martins N (2020) Turmeric and its major compound curcumin on health: bioactive effects and safety profiles for food, pharmaceutical. Biotechnol Med Appl Front Pharmacol 11:01021. https:\/\/doi.org\/10.3389\/fphar.2020.01021","journal-title":"Biotechnol Med Appl Front Pharmacol"},{"issue":"23","key":"1823_CR90","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1089\/neu.2015.4177","volume":"33","author":"SS Shim","year":"2016","unstructured":"Shim SS, Stutzmann GE (2016) Inhibition of glycogen synthase kinase-3: an emerging target in the treatment of traumatic brain injury. J Neurotrauma 33(23):2065\u20132076. https:\/\/doi.org\/10.1089\/neu.2015.4177","journal-title":"J Neurotrauma"},{"issue":"10","key":"1823_CR91","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.cell.2021.03.032","volume":"184","author":"MK Shin","year":"2021","unstructured":"Shin MK, V\u00e1zquez-Rosa E, Koh Y, Dhar M, Chaubey K, Cintr\u00f3n-P\u00e9rez CJ, Barker S, Miller E, Franke K, Noterman MF, Seth D, Allen RS, Motz CT, Rao SR, Skelton LA, Pardue MT, Fliesler SJ, Wang C, Tracy TE, Gan L, Liebl DJ, Savarraj JPJ, Torres GL, Ahnstedt H, McCullough LD, Kitagawa RS, Choi HA, Zhang P, Hou Y, Chiang CW, Li L, Ortiz F, Kilgore JA, Williams NS, Whitehair VC, Gefen T, Flanagan ME, Stamler JS, Jain MK, Kraus A, Cheng F, Reynolds JD, Pieper AA (2021) Reducing acetylated tau is neuroprotective in brain injury. Cell 184(10):2715-2732.e23. https:\/\/doi.org\/10.1016\/j.cell.2021.03.032","journal-title":"Cell"},{"key":"1823_CR92","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","volume":"19","author":"D Singh","year":"2022","unstructured":"Singh D (2022) Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer\u2019s disease. J Neuroinflammation 19:206. https:\/\/doi.org\/10.1186\/s12974-022-02565-0","journal-title":"J Neuroinflammation"},{"issue":"10","key":"1823_CR93","doi-asserted-by":"publisher","first-page":"918","DOI":"10.2174\/1570159X18666200207120949","volume":"18","author":"S Singh","year":"2020","unstructured":"Singh S, Singh TG (2020) Role of nuclear factor kappa B (NF-\u03baB) signalling in neurodegenerative diseases: an mechanistic approach. Curr Neuropharmacol 18(10):918\u2013935. https:\/\/doi.org\/10.2174\/1570159X18666200207120949","journal-title":"Curr Neuropharmacol"},{"issue":"7","key":"1823_CR94","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s00134-023-07141-5","volume":"49","author":"MB Skrifvars","year":"2023","unstructured":"Skrifvars MB, Luethi N, Bailey M, French C, Nichol A, Trapani T, McArthur C, Arabi YM, Bendel S, Cooper DJ, Bellomo R (2023) The effect of recombinant erythropoietin on long-term outcome after moderate-to-severe traumatic brain injury. Intensive Care Med 49(7):831\u2013839. https:\/\/doi.org\/10.1007\/s00134-023-07141-5","journal-title":"Intensive Care Med"},{"issue":"2","key":"1823_CR95","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00004647-200002000-00019","volume":"20","author":"PF Stahel","year":"2000","unstructured":"Stahel PF, Shohami E, Younis FM, Kariya K, Otto VI, Lenzlinger PM, Grosjean MB, Eugster HP, Trentz O, Kossmann T, Morganti-Kossmann MC (2000) Experimental closed head injury: analysis of neurologic outcome, blood\u2013brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. J Cereb Blood Flow Metab 20(2):369\u2013380. https:\/\/doi.org\/10.1097\/00004647-200002000-00019","journal-title":"J Cereb Blood Flow Metab"},{"key":"1823_CR96","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.semcdb.2019.05.004","volume":"94","author":"CS Subhramanyam","year":"2019","unstructured":"Subhramanyam CS, Wang C, Hu Q, Dheen ST (2019) Microglia-mediated neuroinflammation in neurodegenerative diseases. Semin Cell Dev Biol 94:112\u2013120. https:\/\/doi.org\/10.1016\/j.semcdb.2019.05.004","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"1823_CR97","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1474-4422(06)70630-5","volume":"6","author":"NR Temkin","year":"2007","unstructured":"Temkin NR, Anderson GD, Winn HR, Ellenbogen RG, Britz GW, Schuster J, Lucas T, Newell DW, Mansfield PN, Machamer JE, Barber J (2007) Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Lancet Neurol 6(1):29\u201338. https:\/\/doi.org\/10.1016\/S1474-4422(06)70630-5","journal-title":"Lancet Neurol"},{"issue":"9","key":"1823_CR98","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s12031-021-01841-7","volume":"71","author":"K Thapa","year":"2021","unstructured":"Thapa K, Khan H, Singh TG, Kaur A (2021) Traumatic brain injury: mechanistic insight on pathophysiology and potential therapeutic targets. J Mol Neurosci 71(9):1725\u20131742. https:\/\/doi.org\/10.1007\/s12031-021-01841-7","journal-title":"J Mol Neurosci"},{"issue":"5","key":"1823_CR99","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/humrep\/dex023","volume":"32","author":"H Tournaye","year":"2017","unstructured":"Tournaye H, Sukhikh GT, Kahler E, Griesinger G (2017) A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum Reprod 32(5):1019\u20131027. https:\/\/doi.org\/10.1093\/humrep\/dex023","journal-title":"Hum Reprod"},{"issue":"7","key":"1823_CR100","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1089\/10799909931364","volume":"19","author":"V Trembovler","year":"1999","unstructured":"Trembovler V, Beit-Yannai E, Younis F, Gallily R, Horowitz M, Shohami E (1999) Antioxidants attenuate acute toxicity of tumor necrosis factor-alpha induced by brain injury in rat. J Interferon Cytokine Res 19(7):791\u2013795. https:\/\/doi.org\/10.1089\/10799909931364","journal-title":"J Interferon Cytokine Res"},{"key":"1823_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105080","volume":"145","author":"EA Van Vliet","year":"2020","unstructured":"Van Vliet EA, Ndode-Ekane XE, Lehto LJ et al (2020) Long-lasting blood-brain barrier dysfunction and neuroinflammation after traumatic brain injury. Neurobiol Dis 145:105080. https:\/\/doi.org\/10.1016\/j.nbd.2020.105080","journal-title":"Neurobiol Dis"},{"issue":"5","key":"1823_CR102","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3390\/antiox9040297","volume":"97","author":"MA Vella","year":"2017","unstructured":"Vella MA, Crandall ML, Patel MB (2017) Acute management of traumatic brain injury. Surg Clin 97(5):1015\u20131030. https:\/\/doi.org\/10.3390\/antiox9040297","journal-title":"Surg Clin"},{"issue":"6","key":"1823_CR103","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s13311-023-01428-7","volume":"20","author":"TA Verdoorn","year":"2023","unstructured":"Verdoorn TA, Parry TJ, Pinna G, Lifshitz J (2023) Neurosteroid receptor modulators for treating traumatic brain injury. Neurotherapeutics 20(6):1603\u20131615. https:\/\/doi.org\/10.1007\/s13311-023-01428-7","journal-title":"Neurotherapeutics"},{"issue":"3","key":"1823_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282424","volume":"18","author":"P Vlachogiannis","year":"2023","unstructured":"Vlachogiannis P, Hillered L, Enblad P, Ronne-Engstr\u00f6m E (2023) Elevated levels of several chemokines in the cerebrospinal fluid of patients with subarachnoid hemorrhage are associated with worse clinical outcome. PLoS ONE 18(3):e0282424. https:\/\/doi.org\/10.1371\/journal.pone.0282424","journal-title":"PLoS ONE"},{"issue":"11","key":"1823_CR105","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1007\/s10495-010-0481-0","volume":"15","author":"Y Wang","year":"2010","unstructured":"Wang Y, Qin ZH (2010) Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 15(11):1382\u20131402. https:\/\/doi.org\/10.1007\/s10495-010-0481-0","journal-title":"Apoptosis"},{"issue":"4","key":"1823_CR106","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.annemergmed.2006.07.932","volume":"49","author":"DW Wright","year":"2007","unstructured":"Wright DW, Kellermann AL, Hertzberg VS, Clark PL, Frankel M, Goldstein FC, Salomone JP, Dent LL, Harris OA, Ander DS, Lowery DW (2007) ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med 49(4):391\u2013402. https:\/\/doi.org\/10.1016\/j.annemergmed.2006.07.932","journal-title":"Ann Emerg Med"},{"issue":"3","key":"1823_CR107","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cjtee.2018.02.003","volume":"21","author":"Y Xiong","year":"2018","unstructured":"Xiong Y, Mahmood A, Chopp M (2018a) Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities. Chin J Traumatol 21(3):137\u2013151. https:\/\/doi.org\/10.1016\/j.cjtee.2018.02.003","journal-title":"Chin J Traumatol"},{"issue":"03","key":"1823_CR108","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cjtee.2018.02.003","volume":"21","author":"Y Xiong","year":"2018","unstructured":"Xiong Y, Mahmood A, Chopp M (2018b) Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities. Chin J Traumatol 21(03):137\u2013151. https:\/\/doi.org\/10.1016\/j.cjtee.2018.02.003","journal-title":"Chin J Traumatol"},{"issue":"6","key":"1823_CR109","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1097\/JS9.0000000000001367","volume":"110","author":"Z Ye","year":"2024","unstructured":"Ye Z, Li Z, Zhong S, Xing Q, Li K, Sheng W, Shi X, Bao Y (2024) The recent two decades of traumatic brain injury: a bibliometric analysis and systematic review. Int J Surg 110(6):3745\u20133759. https:\/\/doi.org\/10.1097\/JS9.0000000000001367","journal-title":"Int J Surg"},{"key":"1823_CR110","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","volume":"9","author":"M Yi","year":"2024","unstructured":"Yi M, Li T, Niu M et al (2024) Targeting cytokine and chemokine signaling pathways for cancer therapy. Sig Transduct Target Ther 9:176. https:\/\/doi.org\/10.1038\/s41392-024-01868-3","journal-title":"Sig Transduct Target Ther"},{"issue":"15","key":"1823_CR111","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.3390\/molecules27154961","volume":"27","author":"M Yousaf","year":"2022","unstructured":"Yousaf M, Chang D, Liu Y, Liu T, Zhou X (2022) Neuroprotection of cannabidiol, its synthetic derivatives and combination preparations against microglia-mediated neuroinflammation in neurological disorders. Molecules 27(15):4961. https:\/\/doi.org\/10.3390\/molecules27154961","journal-title":"Molecules"},{"issue":"6","key":"1823_CR112","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41590-022-01208-z","volume":"23","author":"L Yshii","year":"2022","unstructured":"Yshii L, Pasciuto E, Bielefeld P, Mascali L, Lemaitre P, Marino M, Dooley J, Kouser L, Verschoren S, Lagou V, Kemps H (2022) Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammation. Nat Immunol 23(6):878\u2013891. https:\/\/doi.org\/10.1038\/s41590-022-01208-z","journal-title":"Nat Immunol"},{"issue":"1","key":"1823_CR113","doi-asserted-by":"publisher","first-page":"9860855","DOI":"10.1155\/2022\/9860855","volume":"2022","author":"MY Zamanian","year":"2022","unstructured":"Zamanian MY, Taheri N, Opulencia MJ, Bokov DO, Abdullaev SY, Gholamrezapour M, Heidari M, Bazmandegan G (2022) Neuroprotective and anti-inflammatory effects of pioglitazone on traumatic brain injury. Mediators Inflamm 2022(1):9860855. https:\/\/doi.org\/10.1155\/2022\/9860855","journal-title":"Mediators Inflamm"},{"issue":"2","key":"1823_CR114","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.cyto.2011.07.018","volume":"56","author":"J Zhao","year":"2011","unstructured":"Zhao J, Li G, Zhang Y, Su X, Hang C (2011) The potential role of JAK2\/STAT3 pathway on the anti-apoptotic effect of recombinant human erythropoietin (rhEPO) after experimental traumatic brain injury of rats. Cytokine 56(2):343\u2013350. https:\/\/doi.org\/10.1016\/j.cyto.2011.07.018","journal-title":"Cytokine"},{"issue":"1","key":"1823_CR115","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bbadis.2017.10.004","volume":"1864","author":"RP Zhou","year":"2018","unstructured":"Zhou RP, Dai BB, Xie YY, Wu XS, Wang ZS, Li Y, Wang ZQ, Zu SQ, Ge JF, Chen FH (2018) Interleukin-1\u03b2 and tumor necrosis factor-\u03b1 augment acidosis-induced rat articular chondrocyte apoptosis via nuclear factor-kappaB-dependent upregulation of ASIC1a channel. Biochim Biophys Acta 1864(1):162\u2013177. https:\/\/doi.org\/10.1016\/j.bbadis.2017.10.004","journal-title":"Biochim Biophys Acta"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01823-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01823-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01823-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T12:03:31Z","timestamp":1750680211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01823-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":115,"alternative-id":["1823"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01823-w","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}